OnKure Therapeutics Stock Forecast

Stock Price Forecast

The 4 analysts that cover OnKure Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $32.25, which forecasts a 1200.4% increase in the stock price over the next year. The lowest target is $30 and the highest is $34.

Price Target: $32.25 (+1200.4%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$30	$32.25	$33	$34
Change	+1109.7%	+1200.4%	+1230.6%	+1271.0%

* Price targets were last updated on Mar 18, 2025.

Analyst Ratings

The average analyst rating for OnKure Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '25	Feb '25	Mar '25	Apr '25	May '25	Jun '25
Strong Buy	2	2	2	2	2	2
Buy	2	2	2	2	2	2
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	4	4	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Robert Burns HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $40 → $34	Strong Buy	Maintains	$40 → $34	+1,270.97%	Mar 18, 2025
Matt Biegler Oppenheimer	Oppenheimer	Buy Maintains $35 → $30	Buy	Maintains	$35 → $30	+1,109.68%	Mar 11, 2025
Soumit Roy Jones Trading	Jones Trading	Strong Buy Initiates $32	Strong Buy	Initiates	$32	+1,190.32%	Jan 28, 2025
Andrew Berens Leerink Partners	Leerink Partners	Buy Initiates $33	Buy	Initiates	$33	+1,230.65%	Dec 5, 2024
Robert Burns HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $40	Strong Buy	Reiterates	$40	+1,512.90%	Nov 8, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 680.00K

Revenue Next Year

n/a

EPS This Year

-5.29

from -15.28

EPS Next Year

-2.89

from -5.29

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	510.00K	680.00K	680.00K
Revenue Growth	-	33.33%	-	-	-	-
EPS	-	-124.41	-15.28	-5.29	-2.89	-2.62
EPS Growth	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-
No. Analysts	-	-	-	7	5	5

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	2.1M	2.1M	2.1M
Avg	510,000	680,003	680,003
Low	n/a	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026	2027
High	208.8%	311.8%	208.8%
Avg	-25.0%	33.3%	-
Low	-	-	-

EPS Forecast

EPS	2025	2026	2027
High	-5.31	-2.61	-2.37
Avg	-5.29	-2.89	-2.62
Low	-5.23	-3.12	-2.82

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.